| P2093 | author name string | N Pfeiffer | |
| | F H Grus | |
| | S Kunst | |
| | N Von Thun Und Hohenstein-Blaul | |
| P2860 | cites work | The Barbados Eye Study. Prevalence of open angle glaucoma | Q42596594 |
| | Enhanced Characterization of Serum Autoantibody Reactivity Following HSP 60 Immunization in a Rat Model of Experimental Autoimmune Glaucoma | Q42881025 |
| | Analysis of autoantibody repertoires in sera of patients with glaucoma. | Q44709853 |
| | Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions. | Q45926332 |
| | Complex antibody profile changes in an experimental autoimmune glaucoma animal model. | Q46003233 |
| | Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens | Q46440971 |
| | Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens | Q48834661 |
| | New insights into autoantibody profiles from immune privileged sites in the eye: a glaucoma study | Q48948028 |
| | Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture. | Q51581253 |
| | Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork. | Q53958100 |
| | The myth of "21". | Q53971758 |
| | Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. | Q54109564 |
| | Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma | Q70999763 |
| | Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor | Q80572007 |
| | Ophthalmopathology in rats with MBP-induced experimental autoimmune encephalomyelitis | Q83462653 |
| | Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model | Q87041812 |
| | GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57 | Q87046490 |
| | Dynamics, alterations, and consequences of minimally invasive intraocular pressure elevation in rats | Q87067807 |
| | The number of people with glaucoma worldwide in 2010 and 2020 | Q24679554 |
| | Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens | Q27334415 |
| | Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 |
| | Oxidative stress and the regulation of complement activation in human glaucoma | Q28577665 |
| | Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial | Q30881058 |
| | Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial | Q31113402 |
| | The Finnish evidence-based guideline for open-angle glaucoma. | Q31134829 |
| | IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma | Q33300223 |
| | Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens | Q33314556 |
| | Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. | Q33358097 |
| | Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma | Q33693579 |
| | Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study | Q33878922 |
| | New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor. | Q34278577 |
| | Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina | Q34603641 |
| | Morphometric changes in the rat optic nerve following short-term intermittent elevations in intraocular pressure. | Q34662227 |
| | γ-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway | Q35111136 |
| | Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway | Q35676010 |
| | An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma | Q35885791 |
| | Glaucoma related Proteomic Alterations in Human Retina Samples | Q36079578 |
| | Molecular biomarkers in glaucoma | Q36530573 |
| | Müller cells in the healthy and diseased retina | Q36535340 |
| | Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis | Q36604735 |
| | Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma | Q36811368 |
| | The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. | Q36967391 |
| | Number of people with glaucoma worldwide | Q37320324 |
| | The case for autoimmunity in glaucoma | Q37783777 |
| | Vascular risk factors in glaucoma: a review. | Q37802923 |
| | Does autoimmunity play a part in the pathogenesis of glaucoma? | Q38094462 |
| | Role of crystallins in ocular neuroprotection and axonal regeneration | Q38226723 |
| | Evaluating treatments for childhood cancer. A process for critical appraisal of the literature and a summary of the results | Q38573502 |
| | Complex autoantibody repertoires in patients with glaucoma | Q39677385 |
| | Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States | Q40347336 |
| | An Evaluation of Optic Disc and Nerve Fiber Layer Examinations in Monitoring Progression of Early Glaucoma Damage | Q41127698 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 225-231 | |
| P577 | publication date | 2017-01-13 | |
| P1433 | published in | Eye | Q10278937 |
| P1476 | title | Biomarkers for glaucoma: from the lab to the clinic | |
| P478 | volume | 31 | |